Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis

(1) Background: Among new anti-angiogenesis agents being developed and ever-changing guidelines indications, the question of the benefits/safety ratio remains unclear. (2) Methods: We performed a systematic review combined with a meta-analysis of 23 randomized controlled trials (12,081 patients), ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Simion, Laurentiu, Rotaru, Vlad, Cirimbei, Ciprian, Stefan, Daniela-Cristina, Gherghe, Mirela, Ionescu, Sinziana, Tanase, Bogdan Cosmin, Luca, Dan Cristian, Gales, Laurentia Nicoleta, Chitoran, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046967/
https://www.ncbi.nlm.nih.gov/pubmed/36980348
http://dx.doi.org/10.3390/diagnostics13061040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046967/
https://www.ncbi.nlm.nih.gov/pubmed/36980348
http://dx.doi.org/10.3390/diagnostics13061040

Ejemplares similares